VivoSim Labs, Inc (VIVS) Diversifiers

Equity · Currency in USD · Last updated Jun 4, 2026

VivoSim Labs, Inc. provides testing of drugs and drug candidates using three-dimensional (3D) human tissue models of liver and intestine, offering liver and intestinal toxicology insights through new approach methodologies (NAM) models. The company develops functional 3D human tissues to mimic native human tissue composition and function, delivering bespoke services in investigational toxicology, mechanism of drug action elucidation, predictive screening, and research to study drug side effect profiles and develop novel human normal and disease models using high throughput, bioprinted, and flow/stretch capable 3D systems.

Looking to balance out your exposure to VIVS? The ETFs below have the lowest correlation with VIVS — they tend to move on their own, which can help reduce risk when VIVS drops. The stock ideas table highlights individual companies that behave independently from VIVS.

No Diversifiers Found for VIVS

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements VIVS

Add VIVS to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with VIVS